Availability depends on medical history, clinical eligibility, patient location, doctor licensure, pharmacy capabilities, applicable federal and state law, and future FDA action
...You threaten the practice of compounding altogether if you continue to do it in a way that's not intended, that puts risk or undue risk to our patient population. Advertisement Article continues below this ad A tale of two pharmacies Compounding pharmacy errors were linked to at least 1,562 adverse events or patient harm associated with a drug nationwide between 2001 and 2019, according to a survey from The Pew Charitable Trusts

GHK-Cu half-life and blood clearance Plasma half-life: Approximately 30-60 minutes in circulation Varies by administration route Injectable: ~30-45 minutes Topical: Similar once absorbed (slower absorption though) Very short compared to some peptides What half-life means: Time for 50% of peptide to clear from blood After one half-life: 50% remains After two half-lives (1-2 hours): 25% remains After three half-lives (1.5-3 hours): 12.5% remains After four half-lives (2-4 hours): 6.25% remains Essentially cleared within 4-6 hours GHK-Cu clearance timeline: Why such short half-life: Small peptide (easily filtered by kidneys) Rapidly metabolized by enzymes Not designed for long circulation Acts quickly at cellular level then clears Learn peptide basics at SeekPeptides - explore what are peptides , how peptides work , and copper peptides GHK-Cu guide
Solution should be clear and colorless
It cant be patented and it promotes human autonomy two things the sick-care system tirelessly fights to fix